Discussion
Consider the following statements :
1. Nafithromycin is India's first indigenously developed antibiotic aimed at tackling Antimicrobial Resistance (AMR).
2. It has been developed by Wockhardt with support from BIRAC and is marketed under the trade name "Miqnaf".
3. It is intended for the treatment of Community-Acquired Bacterial Pneumonia (CABP).
How many of the statements given above is/are correct ?
Answer: C
All three statements are correct: All three.
Nafithromycin was announced in late 2024 as India's first indigenously developed antibiotic against drug-resistant infections, a step against antimicrobial resistance. It was developed by Wockhardt with support from BIRAC, the Biotechnology Industry Research Assistance Council of the Department of Biotechnology, and is sold under the brand name Miqnaf.
It is meant for community-acquired bacterial pneumonia, including infections caused by drug-resistant bacteria. So each of the three statements matches the official description.
Post your comment
Please log in or register to post a comment.
Examination Categories
- SSC Exams
- Banking Exams
- Teaching Exams
- Civil Services Exams
- Railways Exams
- Engineering Recruitment Exams
- Defence Exams
- State Government Exams
- Police Exams
- Insurance Exams
- Nursing Exams
- Other Government Exams
- NRA CET
- PG Entrance Exams
- Campus Placement
- MBA Entrance Exams
- CUET and UG Entrance
- Judiciary Exams
- Regulatory Body Exams
- Software Development